Allergan, Inc.

Sukhon Likitlersuang

Rhett M Schiffman

Richard S Graham

Chetan Pujara

William F Kelly

Anuradha V Gore

Kevin S Warner

Ajay P Parashar

Jie Shen

Marina Bejanian

Sesha Neervannan

Jaya Giyanani

Robert S Jordan

Sai Shankar

Mu-Lan Lee

Chetan P Pujara

The present invention is directed to preservative-free solutions of brimonidine and timolol for lowering intra-ocular pressure and treatment of glaucoma.

Preservative free brimonidine and timolol solutions

Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.

Two part formulation system for ophthalmic delivery

Stabilized ophthalmic compositions containing omega-3 oils are provided, which are useful as artificial tears and as ophthalmic compositions to diagnose, treat, or prevent keratoconjunctivitis or dry eye syndrome in a human or other mammal.

Stabilized omega-3 ophthalmic compositions

The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intraocular pressure and treatment of glaucoma.

Preservative free bimatoprost and timolol solutions

The present invention is directed to preservative-free solutions of bimatoprost and timolol for lowering intra-ocular pressure and treatment of glaucoma.

Growing community of inventors

Irvine, CA, United States of America

Sukhon Likitlersuang